list of semaglutide drugs A new study is raising concerns about GLP-1 weight loss and eating disorders. Researchers found that 32% patients with eating disorders report having used a weight loss injection at least Ozempic maker slumps further in

Effect of DSIP In Chronic Pain and Depression The use of DSIP in patients with chronic pain and depression, or both, was another important clinical indication for this neuropeptide

Excess glial Put-GABA in both depression and AD has also been associated with impaired synaptic plasticity and/or learning (Jo et al., 2014

Only four clinical studies specifically examined GLP-1RAs in mood disorders (Table 4)

It sparked a broader conversation about: Access to essential medicines Healthcare affordability Intellectual property and public health balance The role of Indian pharma in improving patient outcomes Behind every percentage reduction is a human storya patient who could continue treatment, a family that found hope, and a healthcare system striving to serve more people